Page 10 - B Cell News Today

Researchers evaluated immune responses by B lymphocytes to Pfizer’s severe acute respiratory syndrome coronavirus 2 mRNA vaccine.

Researchers assessed naïve B cells and autoreactivity in severe COVID-19.

In a new study, researchers developed a molecular fate-mapping method for differential detection of antibodies derived from specific B cell clones.

In a new study, researchers analyzed the influence of multiple shots of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Wuhan strain vaccinations on the Omicron variant.

In a new study, researchers pursued two monkeypox virus (MPXV) immune targets, A35R and H3L, that could be deployed in a serological assay to identify recent MPXV cases.

Researchers explored how passive administration of monoclonal antibodies impact the development of immunological memory in response to COVID-19 vaccination.

Researchers assess the impact of extending the interval between primary and booster COVID-19 vaccine doses.

Scientists explored the influence of SARS-CoV-2 extended gap vaccination on the variants of concern neutralization.

Researchers demonstrated differential utilization of the B cell germlines and SARS-CoV-2 spike protein epitopes by cross-neutralizing antibodies in infected, vaccinated and individuals with hybrid immunity.

Researchers evaluated memory B and T cell responses to SARS-CoV-2 before and after the third dose of the BNT162b2 vaccine.